Abstract
Therapeutic alliance is an important mediator of treatment effectiveness across disorders. Yet patients with BPD have specific difficulties with forming stable, trusting bonds, and may experience significant suspiciousness or paranoia, particularly during times of stress. In this context, establishing a trusting relationship can feel like a fast-moving target for both clinicians and patients. Conceptualizing the symptom of paranoia within the framework of interpersonal hypersensitivity is helpful for delivering effective psychoeducation to patients, and for maintaining compassion and mitigating burnout for clinicians. Clinicians working with individuals who have difficulty with interpersonal trust should provide psychoeducation early, be clear about expectations for active collaboration, and be active but not reactive when alliance is ruptured. The expectation for change should not be lost in the struggle to form a trusting relationship, and clinicians must be reflective about whether treatment is helping and should continue (or begin again, in the case of termination). In addition, prescribers should be cautious and judicious about the use of antipsychotic medications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Choi-Kain LW, Albert EB, Gunderson JG. Evidence-based treatments for borderline personality disorder: Implementation, integration, and stepped care. Harvard Rev Psychiatry. 2016;24(5):342–56.
De Panfilis C, Riva P, Preti E, Cabrino C, Marchesi C. When social inclusion is not enough: implicit expectations of extreme inclusion in borderline personality disorder. Personal Disord. 2015;6(4):301–9.
Fertuck EA, Grinband J, Stanley B. Facial trust appraisal negatively biased in borderline personality disorder. Psychiatry Res. 2013;207(3):195–202.
Gunderson JG, Links PS. Handbook of good psychiatric management for borderline personality disorder: American Psychiatric Pub; Washington, D.C., USA. 2014.
Ingenhoven TJ, Duivenvoorden HJ. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains. J Clin Psychopharmacol. 2011;31(4):489–96.
King-Casas B, Sharp C, Lomax-Bream L, Lohrenz T, Fonagy P, Montague PR. The rupture and repair of cooperation in borderline personality disorder. Science. 2008;321(5890):806–10.
Martinho E Jr, Fitzmaurice GM, Frankenburg FR, Zanarini MC. Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up. J Clin Psychopharmacol. 2014;34(4):499–503.
Masland, SR, Hooley, JM. When trust does not come easily: Negative emotional information unduly influences trust judgments for individuals with borderline personality traits. (unpublished manuscript).
Mercer D, Douglass AB, Links PS. Meta-analysis of mood-stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Personal Disord. 2009;23:156–74.
Paolini E, Mezzetti FA, Pierri F, Moretti P. Pharmacological treatment of borderline personality disorder: a retrospective observational study at inpatient unit in Italy. Int J Psychiatry Clin Pract. 2017;21(1):75–9.
Silk KR. The process of managing medications in patients with borderline personality disorder. J Psychiatr Pract. 2011;17(5):311–9.
Stoffers JM, Lieb K. Pharmacotherapy for borderline personality disorder – current evidence and recent trends. Curr Psychiatry Rep. 2015;17:534.
Unoka Z, Seres I, Áspán N, Bódi N, Kéri S. Trust game reveals restricted interpersonal transactions in patients with borderline personality disorder. J Personal Disord. 2009;23(4):399–409.
Vita A, De Peri L, Sacchetti E. Antipsychotics, antidepressants, anticonvulsants, and placebo on the syptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials. J Clin Psychopharmacol. 2011;31(5):613–24.
Zanarini MC, Frankenburg FR, Harned A, Fitzmaurice G. Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow-up. J Clin Psychopharmacol. 2015;35(1):63–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Masland, S.R. (2018). Managing Mistrust, Paranoia, and Relationship Rupture. In: Palmer, B., Unruh, B. (eds) Borderline Personality Disorder. Springer, Cham. https://doi.org/10.1007/978-3-319-90743-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-90743-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90742-0
Online ISBN: 978-3-319-90743-7
eBook Packages: MedicineMedicine (R0)